Serologicals Holdings Acquires Acadiana Ventures to Enhance Product Line and Donor Centers
Serologicals Holdings, Inc., a leading biologic-based pharmaceutical company, has announced the acquisition of Acadiana Ventures, Inc., a company specializing in the production of intravenous immunoglobulin (IVIG). The deal, which positions Serologicals for future opportunities, immediately expands its product line with IVIG, a rapidly growing therapeutic product. The acquisition also more than doubles the company's donor center locations, significantly increasing access to rare antibodies used in diagnostic products.
Key Takeaways:
- Serologicals Holdings has acquired Acadiana Ventures, Inc., a company with 13 FDA-licensed donor centers in the U.S., for an undisclosed amount.
- The acquisition will enable the expansion of Serologicals' product line with IVIG, a rapidly growing therapeutic product.
- The deal more than doubles Serologicals' donor center locations, from 10 to 17, by the end of 1996.
- Acadiana Ventures will be renamed Seramune, Inc. and will operate as a wholly-owned subsidiary of Serologicals Holdings.
- Seramune, Inc. will open 7 new donor centers by the end of 1996, maintaining a presence in the production of IVIG.
- Serologicals Holdings, Inc. operates a global network of facilities, including a clinical laboratory in Atlanta, a monoclonal antibody laboratory, and manufacturing facilities in Scotland and research and development laboratories in England and Norway.
Statistics:
- 13: Number of FDA-licensed donor centers operated by Acadiana Ventures, Inc. in the U.S.
- 7: Number of new donor centers to be opened by Acadiana Ventures (now Seramune, Inc.) by the end of 1996.
- 10: Number of FDA-licensed rare antibody donor centers operated by Serologics Holdings in the U.S.
- 4: Number of territories with research and development laboratories operated by Serologics Holdings (England, Norway, Scotland, and U.S.).
Sources:
- (Health Wire), "Serologicals Holdings Announces Agreement to Acquire Acadiana Ventures, Inc.", (January 4, 1995)